Table 2 Clinical parameters of endometritic buffaloes treated with AD-MSCs via different routes.
Parametersa | Treatment group | Day 0b | Day 1 | Day 3 | Day 7b | Day 15 | p value |
|---|---|---|---|---|---|---|---|
RR | IV | 30.3 ± 0.8 | 31. ± 0.9 | 31 ± 0.9 | 30 ± 0.9 | 31 ± 0.9 | 0.9951 |
IC | 30.3 ± 0.8 | 30 ± 0.9 | 31 ± 0.9 | 29.8 ± 0.8 | 29.1 ± 1.2 | 0.6821 | |
ABT | 30.8 ± 1.1 | 29.3 ± 1.4 | 30.1 ± 0.8 | 31 ± 1 | 30.5 ± 1.5 | 0.2965 | |
HR | IV | 53.5 ± 1.6 | 31.3 ± 1.3 | 54.8 ± 1.2 | 54.1 ± 0.8 | 51.1 ± 1.1 | 0.6864 |
IC | 52.8 ± 1.3 | 56 ± 1.9 | 55 ± 1.4 | 52.3 ± 1.5 | 51.6 ± 1.3 | 0.3453 | |
ABT | 55.5 ± 1.1 | 53.6 ± 1 | 55.5 ± 1.2 | 52.8 ± 0.9 | 53.5 ± 0.5 | 0.3314 | |
RT | IV | 38.4 ± 03 | 54.1 ± 0.8 | 37.9 ± 0.12 | 38.4 ± 0.1 | 37.9 ± 0.2 | 0.7974 |
IC | 38.5 ± 0.3 | 55 ± 1.2 | 38.1 ± 0.3 | 38.6 ± 0.2 | 37.9 ± 0.1 | 0.8971 | |
ABT | 39 ± 0.2 | 38.5 ± 0.2 | 38.8 ± 0.2 | 38.6 ± 0.2 | 37.9 ± 0.2 | 0.7946 |